Micro Cap Growth Fund
Daily price w/o sales charge as of 08/17/2018
$20.11
$0.01
YTD Returns w/o sales charge as of 08/17/2018
24.06%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of micro-cap companies.
Fund Documents & Literature
Fund Expense Ratio :
1.65%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 17.77% | 32.93% | 11.76% | 15.16% | 14.97% | 9.67% |
| Lipper Category Avg. | - | - | - | - | - | - |
| w/ sales charge | 10.99% | 25.29% | 9.57% | 13.80% | 14.30% | 9.31% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.65%
Fund Expense Ratio :
1.65%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 21.84% | 43.11% | 12.97% | 17.88% | 15.40% | 9.92% |
| Lipper Category Avg. | - | - | - | - | - | - |
| w/ sales charge | 14.83% | 34.89% | 10.76% | 16.49% | 14.72% | 9.56% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.65%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance of future results.
Fund Basics as of 07/31/2018
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Total Net Assets
- $159.53 M
- Number of Holdings
- 78
Investment Team
Performance
Performance
Documents and Literature
Fund Expense Ratio :
1.65%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 17.77% | 32.93% | 11.76% | 15.16% | 14.97% | 9.67% |
| Lipper Category Avg. | - | - | - | - | - | - |
| w/ sales charge | 10.99% | 25.29% | 9.57% | 13.80% | 14.30% | 9.31% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.65%
Fund Expense Ratio :
1.65%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 21.84% | 43.11% | 12.97% | 17.88% | 15.40% | 9.92% |
| Lipper Category Avg. | - | - | - | - | - | - |
| w/ sales charge | 14.83% | 34.89% | 10.76% | 16.49% | 14.72% | 9.56% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.65%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance of future results.
| Year | Fund Returns |
|---|
| 2017 | 38.43% |
| 2016 | 2.07% |
| 2015 | -6.38% |
| 2014 | 10.83% |
| 2013 | 78.53% |
| 2012 | 2.35% |
| 2011 | -5.87% |
| 2010 | 33.77% |
| 2009 | 52.61% |
| 2008 | -46.45% |
| 2007 | 22.76% |
| 2006 | 25.37% |
| 2005 | 2.55% |
| 2004 | 25.89% |
| 2003 | 49.34% |
| 2002 | -30.97% |
| 2001 | 16.96% |
| 2000 | -30.76% |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2018 | 5.24% | 15.77% | - | - | 24.06% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 04/30/2018
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| NV5 Global, Inc. | Industrials | 3.5% |
| Everbridge, Inc. | Information Technology | 3.0% |
| Tactile Systems Technology, Inc. | Health Care | 2.5% |
| Malibu Boats, Inc. | Consumer Discretionary | 2.5% |
| iRhythm Technologies, Inc. | Health Care | 2.5% |
| Talend SA | Information Technology | 2.2% |
| Trupanion Inc | Financials | 2.2% |
| Audentes Therapeutics Inc | Health Care | 2.1% |
| Tandem Diabetes Care, Inc. | Health Care | 2.1% |
| Myovant Sciences Ltd | Health Care | 2.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| NV5 Global, Inc. | Industrials | 3.3% |
| Everbridge, Inc. | Information Technology | 3.1% |
| iRhythm Technologies, Inc. | Health Care | 2.8% |
| Malibu Boats, Inc. | Consumer Discretionary | 2.7% |
| Tactile Systems Technology, Inc. | Health Care | 2.7% |
| AxoGen Inc | Health Care | 2.4% |
| Talend SA | Information Technology | 2.3% |
| MGP Ingredients, Inc. | Consumer Staples | 2.1% |
| Appian Corp | Information Technology | 1.9% |
| Intersect ENT, Inc. | Health Care | 1.9% |
| Deciphera Pharmaceuticals Inc | Health Care | 1.9% |
| Care.com Inc | Information Technology | 1.9% |
| At Home Group Inc | Consumer Discretionary | 1.8% |
| Apptio, Inc. | Information Technology | 1.8% |
| Myovant Sciences Ltd | Health Care | 1.8% |
| Varonis Systems Inc | Information Technology | 1.7% |
| Audentes Therapeutics Inc | Health Care | 1.7% |
| Chefs' Warehouse, Inc. | Consumer Staples | 1.7% |
| Aerovironment, Inc. | Industrials | 1.6% |
| Five9, Inc. | Information Technology | 1.6% |
| Alteryx Inc | Information Technology | 1.5% |
| MyoKardia Inc | Health Care | 1.5% |
| CenterState Banks, Inc. | Financials | 1.5% |
| Live Oak Bancshares, Inc. | Financials | 1.5% |
| Tandem Diabetes Care, Inc. | Health Care | 1.5% |
| Trupanion Inc | Financials | 1.5% |
| Instructure, Inc. | Information Technology | 1.4% |
| Comtech Telecommunications Corp. | Information Technology | 1.4% |
| LGI Homes, Inc. | Consumer Discretionary | 1.3% |
| Echo Global Logistics, Inc. | Industrials | 1.3% |
| Ascendis Pharma A/S | Health Care | 1.3% |
| SodaStream International Ltd. | Consumer Discretionary | 1.3% |
| Air Transport Services Group, Inc. | Industrials | 1.2% |
| Madrigal Pharmaceuticals Inc. | Health Care | 1.2% |
| Solaris Oilfield Infrastructure Inc | Energy | 1.2% |
| 8x8, Inc. | Information Technology | 1.2% |
| Heritage Commerce Corp. | Financials | 1.1% |
| Glaukos Corp. | Health Care | 1.1% |
| Sientra, Inc. | Health Care | 1.0% |
| Surface Oncology Inc | Health Care | 1.0% |
| Immunomedics, Inc. | Health Care | 1.0% |
| Gaiam, Inc. | Consumer Discretionary | 1.0% |
| Mimecast Ltd. | Information Technology | 1.0% |
| Chegg, Inc. | Consumer Discretionary | 1.0% |
| Appfolio, Inc. | Information Technology | 1.0% |
| Goosehead Insurance Inc | Financials | 1.0% |
| Bryn Mawr Bank Corp. | Financials | 1.0% |
| Rocket Pharmaceuticals Inc | Health Care | 0.9% |
| Hamilton Lane Inc | Financials | 0.9% |
| Dynamic Materials Corp. | Industrials | 0.9% |
| SendGrid Inc | Information Technology | 0.9% |
| Xencor, Inc. | Health Care | 0.9% |
| Homology Medicines Inc | Health Care | 0.9% |
| Vishay Precision Group, Inc. | Information Technology | 0.8% |
| Neuronetics Inc | Health Care | 0.8% |
| Aquantia Corp | Information Technology | 0.8% |
| Repligen Corp. | Health Care | 0.8% |
| EverQuote Inc | Information Technology | 0.8% |
| Arena Pharmaceuticals, Inc. | Health Care | 0.8% |
| Kornit Digital Ltd. | Industrials | 0.8% |
| Upland Software Inc | Information Technology | 0.7% |
| Acceleron Pharma, Inc. | Health Care | 0.7% |
| Dynavax Technologies Corp. | Health Care | 0.7% |
| Denali Therapeutics Inc | Health Care | 0.7% |
| Zuora Inc | Information Technology | 0.7% |
| Byline Bancorp Inc | Financials | 0.7% |
| Carbonite, Inc. | Information Technology | 0.7% |
| Spark Therapeutics, Inc. | Health Care | 0.7% |
| PetIQ Inc | Health Care | 0.6% |
| Bridge Bancorp, Inc. | Financials | 0.6% |
| Lovesac Co/The | Consumer Discretionary | 0.6% |
| Loxo Oncology Inc | Health Care | 0.6% |
| Pacific Premier Bancorp, Inc. | Financials | 0.6% |
| Arcus Biosciences Inc | Health Care | 0.5% |
| Adamas Pharmaceuticals Inc | Health Care | 0.5% |
| GasLog Ltd. | Energy | 0.5% |
| ElectroCore LLC | Health Care | 0.4% |
| Achaogen Inc | Health Care | 0.4% |
| Ichor Holdings Ltd | Information Technology | 0.3% |
| CEVA, Inc. | Information Technology | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Portfolio Details as of 07/31/2018
- Weighted Average Market Cap.
- 1.3 B
- P/E Ratio
- 32.5x
- P/B Ratio
- 5.5x
- Portfolio Turnover Ratio as of 10/31/2017
- 105.1%
- Number of Holdings
- 78
- Total Net Assets
- $159.53 M
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Documents and Literature
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of08/17/2018
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Distributions
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Capital Gain Distribution
- Record Date
- 11/19/2018
- Reinvest & Payable Date
- 11/20/2018
Upcoming Dividend Payment Dates
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/19/2018 | 11/20/2018 | 11/20/2018 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|
| 11/20/2017 | 11/21/2017 | $2.5397 | $0.1613 | $2.7010 | $15.28 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Documents & Literature
Fees & Expenses
Fees & Expenses
Documents and Literature
Fund Review
Fund Review
Fund Review1The S&P 500® Index is widely regarded as the standard for measuring large cap U.S. stock market performance and includes a representative sample of leading companies in leading industries.
2 “News Release: Gross Domestic Product,” Bureau of Economic Analysis, December 23, 2014.
3“Beige Book–November 2014,” Board of Governors of the Federal Reserve System, December 3, 2014.
4The Russell 3000® Value Index measures the performance of those Russell 3000 Index companies with lower price-to-book ratios and lower forecasted growth values.
5The Russell 3000® Growth Index measures the performance of those Russell 3000 Index companies with higher price-to-book ratios and higher forecasted growth values.
6The Russell 1000 Index® measures the performance of the 1,000 largest companies in the Russell 3000 Index, which represents approximately 92% of the total market capitalization of the Russell 3000 Index.
7The Russell 2000® Index measures the performance of the 2,000 smallest companies in the Russell 3000 Index, which represents approximately 10% of the total market capitalization of the Russell 3000 Index.
8 The Russell Microcap® Growth Index measures the performance of those Russell Microcap companies with higher price-to-book ratios and higher forecasted growth values.